Levine Tox Consulting

Levine Tox Consulting

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Levine Tox Consulting is a Boston-based, privately-held consultancy founded in 2012, operating in the drug development services sector. The firm is led by Dr. Barry Levine, a board-certified toxicologist with 43+ years of industry experience, and provides strategic guidance on nonclinical testing programs and forensic toxicology. It serves pharmaceutical and biotech clients by offering deep regulatory and scientific expertise to de-risk development pathways and address legal challenges, functioning as a highly specialized service provider rather than a therapeutic developer.

Drug DeliverySmall Molecules

Technology Platform

Intellectual capital and methodological expertise in nonclinical toxicology, pharmacokinetics, safety pharmacology, and regulatory strategy across small molecules, biologics, and biosimilars. Operates as a consulting service model.

Opportunities

Growing complexity of novel drug modalities (e.g., advanced biologics, cell therapies) increases demand for specialized toxicology expertise.
The expansion of the biosimilars market and persistent need for expert witnesses in product liability cases provide diversified service avenues.

Risk Factors

Extreme key-person risk centered on founder Dr.
Barry Levine.
Revenue is susceptible to cyclical downturns in biotech funding, which may reduce client spending on consulting services.

Competitive Landscape

Competes with toxicology consultants at large CROs, specialized boutique consulting firms, and independent experts. Differentiation is based on Dr. Levine's unique depth of experience (43+ years), specific expertise in directing GLP labs, and proven track record across industry, CRO, and academic settings.